Condition: Atherosclerosis · Sponsor: Genentech, Inc.
The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adverse cardiovascular event (MACE), who are currently on standard-of-care (SOC) therapy.
This description comes directly from the study's public registry record.
Reference Study ID Number: GC46102 https://forpatients.roche.com/ · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. No email attachments https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Cardiovascular Research Foundation of Southern California | Beverly Hills, California, United States | Recruiting |
| National Heart Institute | Beverly Hills, California, United States | Recruiting |
| Amnova Clinical Research | Irvine, California, United States | Recruiting |
| Alliance Clinical West Hills (Focus Clinical Research) | West Hills, California, United States | Recruiting |
| Inpatient Research Clinic (Las Palmas Medical Research Center) | Miami Lakes, Florida, United States | Recruiting |
| Asha Clinical Research-Munster,Llc | Hammond, Indiana, United States | Recruiting |
| Profound Research LLC at Cardiology and Vascular Associates - CAVA | Bloomfield Hills, Michigan, United States | Recruiting |
| Profound Research LLC at Millenium Cardiology | Farmington Hills, Michigan, United States | Recruiting |
| Ahmed Arif Medical Research Center (AA MRC LLC ) | Flint, Michigan, United States | Recruiting |
| DiGiovanna Inst for Med Ed&Res | North Massapequa, New York, United States | Recruiting |
| Preferred Primary Care Physicians, Inc | Pittsburgh, Pennsylvania, United States | Recruiting |
| Southwest Family Medicine Associates | Dallas, Texas, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.